Description:

Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5; ODM derived from: https://clinicaltrials.gov/show/NCT02392208

Link:

https://clinicaltrials.gov/show/NCT02392208

Keywords:
Versions (1) ▾
  1. 3/28/19
Copyright Holder:
See clinicaltrials.gov
Uploaded on:

March 28, 2019

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility End-Stage Renal Disease NCT02392208

Eligibility End-Stage Renal Disease NCT02392208

Inclusion Criteria
Exclusion Criteria